The company recently completed a massive expansion in Durham and is acquiring a Raleigh company for billions. Join us as we honor outstanding C-Level Executives for their invaluable contributions to ...

Research & Development: Sartorius Stedim Biotech will collaborate with Bio Usawa to develop state-of-the-art biosimilar cell lines tailored to therapeutic needs in Africa.

Merck’s stock is falling after a rare revenue miss, and the announcement of a $3 billion cost-cutting plan that will include ...

Durham, N.C.-based Duke University has shared plans to lay off 599 employees who had accepted a voluntary separation agreement proffered in the spring. The layoffs include roles among some of Duke ...

The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...

Adaptimmune Therapeutics plans to drastically cut its workforce, including half of its C-suite, in conjunction with the sale ...

These stories show how volatility in global markets is pushing manufacturers to make painful workforce decisions.

A new study finds the growing number of threats at work prompted 45 percent of health care employees to say they're likely to ...

We've now entered the second half of the year, and tech-related layoffs have already skyrocketed past the 100,000 mark. The ...

BioMarin Pharmaceuticals is one of many biotech companies that’s laid off workers over the past two years. Its office in ...

Intel hopes to have just 75,000 core employees by year-end, about a third fewer than it had at the end of 2024.

Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from ...